(Q46076332)

19 December 2017

title

Mycophenolate mofetil is effective in reducing disease flares in systemic lupus erythematosus patients: a retrospective study (English)

1 reference

19 December 2017

author name string

C Nannini

1

1 reference

19 December 2017

C S Crowson

2

1 reference

19 December 2017

E L Matteson

3

1 reference

19 December 2017

K G Moder

4

1 reference

19 December 2017

publication date

1 April 2009

1 reference

19 December 2017

published in

Lupus

1 reference

19 December 2017

volume

18

1 reference

19 December 2017

issue

5

1 reference

19 December 2017

page(s)

394-399

1 reference

19 December 2017

Socioeconomic factors in lupus erythematosus

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0961203308099242

Validity and reliability of retrospective assessment of disease activity and flare in observational cohorts of lupus patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308099242

A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308099242

Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. A long-term, prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308099242

The predictive value of fluctuations in IgM and IgG class anti-dsDNA antibodies for relapses in systemic lupus erythematosus. A prospective long-term observation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308099242

Decreases in anti-double-stranded DNA levels are associated with concurrent flares in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308099242

Criteria for steroid-sparing ability of interventions in systemic lupus erythematosus: report of a consensus meeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308099242

Mycophenolate mofetil for the treatment of systemic lupus erythematosus: an open pilot trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308099242

Mycophenolate mofetil therapy for lupus nephritis refractory to intravenous cyclophosphamide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308099242

Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308099242

Mycophenolate mofetil for systemic lupus erythematosus refractory to other immunosuppressive agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308099242

Mycophenolate mofetil: new applications for this immunosuppressant

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308099242

Cyclophosphamide: new approaches for systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308099242

Mycophenolate mofetil prevents a clinical relapse in patients with systemic lupus erythematosus at risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308099242

Systemic lupus erythematosus. I. Outcome and survival: Dutch experience with 110 patients studied prospectively

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308099242

The 1982 revised criteria for the classification of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308099242

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308099242

Hydroxychloroquine use predicts complete renal remission within 12 months among patients treated with mycophenolate mofetil therapy for membranous lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308099242

Laboratory tests as predictors of disease exacerbations in systemic lupus erythematosus. Why some tests fail

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203308099242

21 January 2018

Identifiers

DOI

10.1177/0961203308099242

1 reference

19 December 2017

1 reference

19 December 2017